RAB6D
gene geneOn this page
Also known as RAB6CLWTH3DI
Summary
RAB6D (RAB6D, member RAS oncogene family, HGNC:30272) is a protein-coding gene on chromosome 2q21.1, encoding Ras-related protein Rab-6D (Q53S08). The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes.
Predicted to enable GTPase activity. Predicted to be involved in several processes, including Golgi vesicle transport; protein localization to Golgi membrane; and retrograde transport, endosome to Golgi. Located in Golgi apparatus; ciliary basal body; and nucleoplasm.
Source: NCBI Gene 150786 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001077637
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30272 |
| Approved symbol | RAB6D |
| Name | RAB6D, member RAS oncogene family |
| Location | 2q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RAB6CL, WTH3DI |
| Ensembl gene | ENSG00000233087 |
| Ensembl biotype | protein_coding |
| Entrez | 150786 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000623617
RefSeq mRNA: 1 — MANE Select: NM_001077637
NM_001077637
CCDS: CCDS82514
Canonical transcript exons
ENST00000623617 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003758111 | 131360492 | 131364168 |
Expression profiles
Bgee: expression breadth broad, 62 present calls, max score 75.45.
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.45 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 64.63 | gold quality |
| quadriceps femoris | UBERON:0001377 | 64.14 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.08 | gold quality |
| cerebellar vermis | UBERON:0004720 | 63.05 | gold quality |
| cortical plate | UBERON:0005343 | 61.25 | gold quality |
| primary visual cortex | UBERON:0002436 | 61.08 | gold quality |
| rectum | UBERON:0001052 | 60.15 | gold quality |
| frontal cortex | UBERON:0001870 | 58.80 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 58.10 | gold quality |
| thymus | UBERON:0002370 | 57.37 | silver quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 57.20 | gold quality |
| cerebral cortex | UBERON:0000956 | 56.76 | gold quality |
| islet of Langerhans | UBERON:0000006 | 56.66 | gold quality |
| hypothalamus | UBERON:0001898 | 54.95 | gold quality |
| prostate gland | UBERON:0002367 | 54.45 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 53.43 | gold quality |
| transverse colon | UBERON:0001157 | 53.37 | gold quality |
| Ammon’s horn | UBERON:0001954 | 52.92 | gold quality |
| ventricular zone | UBERON:0003053 | 52.20 | silver quality |
| nucleus accumbens | UBERON:0001882 | 51.91 | gold quality |
| right frontal lobe | UBERON:0002810 | 50.26 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 49.80 | gold quality |
| temporal lobe | UBERON:0001871 | 49.65 | gold quality |
| duodenum | UBERON:0002114 | 49.62 | gold quality |
| amygdala | UBERON:0001876 | 49.45 | gold quality |
| caudate nucleus | UBERON:0001873 | 49.34 | gold quality |
| small intestine | UBERON:0002108 | 49.29 | gold quality |
| gall bladder | UBERON:0002110 | 49.11 | gold quality |
| stromal cell of endometrium | CL:0002255 | 48.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
115 targeting RAB6D, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-219A-5P | 99.91 | 73.36 | 735 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-4782-3P | 99.88 | 73.31 | 735 |
| HSA-MIR-6766-3P | 99.88 | 73.38 | 732 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-369-3P | 99.85 | 70.52 | 2264 |
Cross-species orthologs
0 orthologs
Paralogs (68): RAB27B (ENSG00000041353), RAB27A (ENSG00000069974), RAB7A (ENSG00000075785), RABL2B (ENSG00000079974), RAB21 (ENSG00000080371), RAB10 (ENSG00000084733), RAB18 (ENSG00000099246), RAB36 (ENSG00000100228), IFT27 (ENSG00000100360), RAB40AL (ENSG00000102128), RAB11A (ENSG00000103769), RAB2A (ENSG00000104388), RAB3D (ENSG00000105514), RAB3A (ENSG00000105649), RAB5C (ENSG00000108774), RAB34 (ENSG00000109113), RAB5B (ENSG00000111540), RAB35 (ENSG00000111737), RAB23 (ENSG00000112210), DNAJC27 (ENSG00000115137), RAB29 (ENSG00000117280), RAB32 (ENSG00000118508), RAB14 (ENSG00000119396), RAB9B (ENSG00000123570), RAB9A (ENSG00000123595), RAB38 (ENSG00000123892), RAB22A (ENSG00000124209), RAB17 (ENSG00000124839), RAB2B (ENSG00000129472), RAB25 (ENSG00000132698), RAB33A (ENSG00000134594), RAB30 (ENSG00000137502), RAB1A (ENSG00000138069), RAB20 (ENSG00000139832), RAB15 (ENSG00000139998), RAB40B (ENSG00000141542), RAB13 (ENSG00000143545), RABL2A (ENSG00000144134), RAB5A (ENSG00000144566), RAB19 (ENSG00000146955)
Protein
Protein identifiers
Ras-related protein Rab-6D — Q53S08 (reviewed: Q53S08)
Alternative names: Rab6-like protein WTH3DI
All UniProt accessions (1): Q53S08
UniProt curated annotations — full annotation on UniProt →
Function. The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion.
Domain organisation. Switch 1, switch 2 and the interswitch regions are characteristic of Rab GTPases and mediate the interactions with Rab downstream effectors. The switch regions undergo conformational changes upon nucleotide binding which drives interaction with specific sets of effector proteins, with most effectors only binding to GTP-bound Rab.
Similarity. Belongs to the small GTPase superfamily. Rab family.
RefSeq proteins (1): NP_001071105* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001806 | Small_GTPase | Family |
| IPR005225 | Small_GTP-bd | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR050227 | Rab | Family |
Pfam: PF00071
Catalyzed reactions (Rhea), 1 shown:
- GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)
UniProt features (20 total): binding site 17, short sequence motif 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q53S08-F1 | 73.66 | 0.45 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (17): 39; 40; 42; 68; 71; 126; 127; 129; 157; 158; 23; 24 …
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 57 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT, GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI, GOBP_LOCALIZATION_WITHIN_MEMBRANE, GOBP_CYTOSOLIC_TRANSPORT, GOCC_CILIUM, GOCC_CILIARY_BASAL_BODY, GOMF_GTPASE_ACTIVITY, GOBP_GOLGI_VESICLE_TRANSPORT, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM
GO Biological Process (5): intracellular protein transport (GO:0006886), retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890), intra-Golgi vesicle-mediated transport (GO:0006891), retrograde transport, endosome to Golgi (GO:0042147), protein localization to Golgi membrane (GO:1903292)
GO Molecular Function (6): GTPase activity (GO:0003924), G protein activity (GO:0003925), GTP binding (GO:0005525), metal ion binding (GO:0046872), nucleotide binding (GO:0000166), hydrolase activity (GO:0016787)
GO Cellular Component (5): nucleoplasm (GO:0005654), Golgi apparatus (GO:0005794), cytosol (GO:0005829), endomembrane system (GO:0012505), ciliary basal body (GO:0036064)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| Golgi vesicle transport | 2 |
| cytoplasm | 2 |
| intracellular protein localization | 1 |
| protein transport | 1 |
| intracellular transport | 1 |
| intercellular transport | 1 |
| endosomal transport | 1 |
| cytosolic transport | 1 |
| protein localization to Golgi apparatus | 1 |
| protein localization to membrane | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| GTPase activity | 1 |
| molecular function regulator activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| cation binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| catalytic activity | 1 |
| nuclear lumen | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| vacuole | 1 |
| plasma membrane | 1 |
| microtubule organizing center | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
330 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RAB6D | SCFD1 | Q8WVM8 | 611 |
| RAB6D | GDI2 | P50395 | 609 |
| RAB6D | USO1 | O60763 | 597 |
| RAB6D | RAB1A | P11476 | 402 |
| RAB6D | RAB7A | P51149 | 400 |
| RAB6D | RAB6A | P20340 | 364 |
| RAB6D | DCTN6 | O00399 | 325 |
| RAB6D | A1CF | Q9NQ94 | 292 |
| RAB6D | RINT1 | Q6NUQ1 | 277 |
| RAB6D | STX8 | Q9UNK0 | 277 |
| RAB6D | SYNGR1 | O43759 | 269 |
| RAB6D | RBM47 | A0AV96 | 256 |
| RAB6D | PIRT | P0C851 | 246 |
| RAB6D | RTCB | Q9Y3I0 | 244 |
| RAB6D | KIF18A | Q8NI77 | 222 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC12A4 | LGALS3 | psi-mi:“MI:0914”(association) | 0.530 |
| RIN3 | psi-mi:“MI:0914”(association) | 0.350 | |
| RAB6C | CAPS | psi-mi:“MI:0914”(association) | 0.350 |
| SLC10A1 | FLOT1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC12A6 | SCAMP1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC2A3 | NRP2 | psi-mi:“MI:0914”(association) | 0.350 |
| CFTR | UBA6 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (9): WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Cross-Linking-MS (XL-MS)), WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Proximity Label-MS)
ESM2 similar proteins: A2YEQ6, O35963, O74536, O95661, O95755, P25378, P35283, P35284, P51156, P52198, P97950, Q00246, Q02723, Q06AU4, Q08AT1, Q08E00, Q09178, Q14088, Q20365, Q29RR0, Q3SXC5, Q3UHC2, Q504M8, Q53S08, Q5H913, Q5JT25, Q5R615, Q5U1Y1, Q5ZHV1, Q62120, Q62689, Q64008, Q69XM7, Q6IQ22, Q75R65, Q7SZ59, Q7TN89, Q7Z444, Q8C0V7, Q8CAM5
Diamond homologs: A4FV54, A6QR46, M0RC99, O18333, O18334, O80501, P05712, P11023, P16976, P17608, P18066, P20336, P20339, P20340, P22127, P22128, P24409, P25228, P29687, P31582, P31583, P34213, P35276, P35278, P35279, P35280, P35292, P36017, P36586, P36863, P49103, P49104, P51147, P51148, P53994, P55258, P61006, P61007, P61019, P61020
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1655 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:131363265:A:C | F152L | 0.877 |
| 2:131363265:A:T | F152L | 0.877 |
| 2:131363267:A:G | F152L | 0.877 |
| 2:131363418:G:C | F101L | 0.849 |
| 2:131363418:G:T | F101L | 0.849 |
| 2:131363420:A:G | F101L | 0.849 |
| 2:131363679:G:C | F14L | 0.844 |
| 2:131363679:G:T | F14L | 0.844 |
| 2:131363681:A:G | F14L | 0.844 |
| 2:131363622:G:C | F33L | 0.830 |
| 2:131363622:G:T | F33L | 0.830 |
| 2:131363624:A:G | F33L | 0.830 |
| 2:131363220:A:C | F167L | 0.779 |
| 2:131363220:A:T | F167L | 0.779 |
| 2:131363222:A:G | F167L | 0.779 |
| 2:131363667:G:C | F18L | 0.777 |
| 2:131363667:G:T | F18L | 0.777 |
| 2:131363669:A:G | F18L | 0.777 |
| 2:131363607:A:C | F38L | 0.762 |
| 2:131363607:A:T | F38L | 0.762 |
| 2:131363609:A:G | F38L | 0.762 |
| 2:131363571:A:C | F50L | 0.724 |
| 2:131363571:A:T | F50L | 0.724 |
| 2:131363573:A:G | F50L | 0.724 |
| 2:131363288:C:G | A145P | 0.682 |
| 2:131363400:C:A | W107C | 0.656 |
| 2:131363400:C:G | W107C | 0.656 |
| 2:131363402:A:G | W107R | 0.648 |
| 2:131363402:A:T | W107R | 0.648 |
| 2:131363259:T:A | E154D | 0.635 |
dbSNP variants (sampled 300 via entrez): RS1003672153 (2:131364083 G>A,C,T), RS1005653017 (2:131361270 C>T), RS1006169203 (2:131366058 TAAAG>T), RS1006614204 (2:131365883 T>TA), RS1007510626 (2:131360480 TCAAA>T), RS1007536705 (2:131360141 G>A), RS1007580529 (2:131361940 A>C,G), RS1008538129 (2:131361773 T>C), RS1010054361 (2:131362061 GT>G), RS1010437267 (2:131362420 A>G), RS1010720708 (2:131365176 C>T), RS1012041642 (2:131365862 A>G), RS1014675223 (2:131361233 TA>T), RS1014952551 (2:131365886 A>G), RS1015397618 (2:131365743 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| FR900359 | increases phosphorylation | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | affects cotreatment, increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Tretinoin | increases expression, affects cotreatment | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.